The Phenotypes of Asthma and the Antagonists of Leukotriene Receptors (Montelukast)
With the emergence on the domestic pharmaceutical market the drug named Almont the opportunities of the leukotriene receptor antagonists use in the clinical practice of pediatricians, allergists, pulmonologists and ENT specialists significantly expanded. As shown by the research results, in patients with bronchial asthma and allergic rhinitis the use of the drug Almont effectively and safely helps control the symptoms of the disease.